Close Menu

NEW YORK — Israeli proteomics firm OncoHost said today that it and its partner RayBiotech have received a $1 million grant from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

The fund will support the companies' development and clinical validation of a test to predict patient response to immunotherapy treatment in non-small cell lung cancer and to develop an automated slide assistance platform to enable large-scale protein processing for host response enrichment work for pharmaceutical companies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.

Sep
09
Sponsored by
10x Genomics

Recent advances in spatially resolved transcriptomics have greatly expanded the knowledge of complex multicellular biological systems.